Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-04-15

Clinical Trial Update: A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Adebrelimab in combination with concurrent chemoradiotherapy versus placebo with concurrent chemoradiotherapy for locally ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adebrelimab (adebrelimab)

Snippet

Sponsor: Shanghai Shengdi Pharmaceutical Co., Ltd | Conditions: Advanced Cervical Cancer | Phase 3 | Status: RECRUITING